ANGPTL4 and ovarian serous adenocarcinoma: We therefore tested the Cancer Genome Atlas (TCGA) cohort of 506 high grade serous ovarian cancer patients [34] for a potential link of ANGPTL4 expression to the clinical outcome of the disease.